Redx Pharma agrees to £26.3m funding injection from Redmile, Sofinnova
Cancer and fibrosis focused Redx Pharma said healthcare investor Redmile had agreed to provide, together with Sofinnova Partners, it with up to £26.3m of funding....
Mon, 02/03/2020 - 09:16